In more details, ALT was still elevated in NASH group compared to NAFLD group (47.9 U/L vs. 37.7 U/L), magnesium reached the reference range in NASH treatment group but was lower than control group (0.77 mmoL/L vs. 0.90 mmoL/L), while HOMA-IR showed a decrease by 1.1 in NASH cohort when compared to NAFLD cohort (Figure 1). This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.